MedPath

Comparison of ultrasound and fluoroscopic guided intra-articular sacroiliac injection in patients with sacroiliac joint disorder

Phase 2
Recruiting
Conditions
Unspecified inflammatory spondylopathy, sacral and sacrococcygeal region
Chronic pain of sacroiliac joint.
M46.98
Registration Number
IRCT20170314033069N4
Lead Sponsor
Vice President of Research Guilan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
122
Inclusion Criteria

Patients over 18 years old who have been nominated for sacroiliac joint injection due to persistent sacroiliac joint pain
Out of 7 tests in clinical examinations, at least 4 examinations are positive
The patient's average pain over the past week is at least 3 out of 10 (in Numerical Rating scale)
The patient has persistent pain for at least 6 weeks and does not respond to at least one or two conservative treatments such as oral medications, anti-inflammatory drugs, analgesics, muscle relaxants, and physical therapies.

Exclusion Criteria

Complaints of lower back pain so that the distinction between sacroiliac joint and L5 / S1 fastogenic back pain is indistinguishable.
Dye contrast sensitivity
Contraindications to fluoroscopy
Active lesion in structures of sacroiliac joint such as lumbar spine pathologies and hip pathology
Secondary orthopathy to rheumatoid causes
Abnormal anatomy
Infection, bleeding and trauma at the site
Previous history of intro-articular injection
Active inflammatory diseases
Untreated coagulopathies

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of pain. Timepoint: Before the procedure, zero time of the procedure, 15 minutes and 24 hours after the procedure. Method of measurement: Based on the Numerical Rating Scale (a scale for pain).;Duration of the procedure. Timepoint: At the end of procedure. Method of measurement: Measuring time based on minutes.;Complications of the procedure (hypotension,urticaria). Timepoint: During the procedure and at the end. Method of measurement: Blood pressure measurement with mercury sphygmomanometer, patient observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath